Pharma
Scientists in large pharmaceuticals, biologics development, gene therapy teams, vaccine development, and therapeutic antibodies.
"We're developing a therapeutic antibody and need maximum expression in CHO cells"
"We're designing a gene therapy and want to verify the transgene expresses correctly in human cells"
"We need to document all codon optimization for the FDA regulatory dossier"
"The patient has a genetic variant and we want to predict if it will affect protein production"
Design genes for biopharmaceutical production (antibodies, therapeutic enzymes) with maximum expression.
Specific optimization for mammalian cell expression (CHO, HEK293) for gene therapies.
Verify that optimization doesn't introduce folding problems in critical therapeutic proteins.
Analyze how patient variants affect expression vs wild-type in personalized therapies.
AI-informed decisions to document in regulatory submissions.
Quantitative metric for Quality by Design (QbD) and regulatory documentation.
Critical IP protection in new drug development.
Complete version traceability for GxP compliance.
Detailed documentation for regulatory files and audits.
Quantifiable metrics and detailed reports for IND/NDA submissions.
